Recombinant LAG3 (Encelimab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects LAG3 (Encelimab Biosimilar) in not_set. It exhibits reactivity toward Human.
Catalog No. ABIN7597659
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant LAG3 (Encelimab Biosimilar) antibody (ABIN7597659)
Target
LAG3 (Encelimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This LAG3 (Encelimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Encelimab Biosimilar Antibody
-
Specificity
- FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- LAG3 (Encelimab Biosimilar)
-
Alternative Name
- Encelimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3
-
UniProt
- P18627
-
CAS-No
- 2173096-82-5
Target
-
You are here:
